NCT02037529 2024-08-20Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerAcademic and Community Cancer Research UnitedPhase 3 Suspended201 enrolled 19 charts
NCT00002696 2013-08-02Combination Chemotherapy in Treating Women With Stage III Breast CancerNational Cancer Institute (NCI)Phase 3 Suspended